Abstract
Introduction: Parkinson disease (PD) is a complex disorder for which both rare and common genetic variants contribute to the pathogenesis. Genetic forms of PD may have different phenotype compared to idiopathic patients. Mutations of the gene for glucocerebrosidase (GBA) have been recognized as the major genetic risk factor for PD. Impulse control behaviours (ICBs) are among the most disabling side effects related to dopamine agonists. Aim of this study was to assess prevalence and severity of ICBs in GBA carriers of PD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
